Diabetic Macular Edema
Diabetic Macular Edema
复制标题
DOI：
10.1159/000455277
复制
发表时间：
2017-01-01
期刊：
影响因子：
--
通讯作者：
Veritti, Daniele
中科院分区：
文献类型：
--
作者：
Bandello, Francesco;Parodi, Maurizio Battaglia;Veritti, Daniele
糖尿病性黄斑水肿（DME），定义为累及或接近黄斑中心的视网膜增厚，是糖尿病患者视力丧失的最常见原因。在过去几年中，许多诊断工具已被证明在检测和监测表征二甲醚的特征方面是有用的。另一方面，现在可以根据二甲醚的特定特征提出几种治疗方法。本章的目的是彻底描述二甲醚的临床和形态功能特征及其目前的治疗前景。DME的发病机制和病程需要一个复杂的方法，在系统和局部层面都需要多学科的干预。(C) 2017 S. Karger AG，巴塞尔
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME. On the other hand, several therapeutic approaches can now be proposed on the basis of the DME-specific characteristics. The aim of the present chapter is to thoroughly delineate the clinical and morphofunctional characteristics of DME and its current treatment perspectives. The pathogenesis and the course of DME require a complex approach with multidisciplinary intervention both at the systemic and local levels. (C) 2017 S. Karger AG, Basel